Novo’s Already Bad Day Was Made Worse by Hims Copycat
Telehealth firm offers obesity pill for a starting price of $49.
This article is for subscribers only.
Hi, it’s Madison in New York. Novo Nordisk was already having a bad day when a compounder announced that it was offering a cheaper weight-loss pill. More on that in a moment, but first ...
Novo Nordisk’s Chief Executive Officer Mike Doustdar was on an earnings call with financial analysts Thursday after warning that sales could drop as much as 13% this year. Then news headlines interrupted the agenda: Telehealth firm Hims & Hers announced that it would offer a cheaper, compounded version of Novo’s new weight-loss pill.